Clinical Trials Logo

Colorectal Cancer Metastatic clinical trials

View clinical trials related to Colorectal Cancer Metastatic.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05584137 Suspended - Clinical trials for Colorectal Cancer Metastatic

Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients With mCRC

Start date: June 15, 2023
Phase: Phase 2
Study type: Interventional

This study is a phase II study to evaluate the efficacy, safety and tolerability of HLX26 and HLX10 in the treatment of patients with metastatic colorectal carcinoma that had received 3 prior therapies.

NCT ID: NCT04108481 Suspended - Rectal Cancer Clinical Trials

Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer

iRE-C
Start date: October 5, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This clinical trial will be conducted as a single-center, open-label, Phase I/2 trial to evaluate the feasibility and safety of Yttrium-90 radioembolization (Y90-RE) in combination with a fixed dose of of immunotherapy (durvalumab - 750 mg) in subjects with liver-predominant, metastatic colorectal cancer (mCRC), which is mismatch repair proficient/microsatellite stable (pMMR/MSS).